Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
Gilead Sciences
GERCOR - Multidisciplinary Oncology Cooperative Group
Merck Sharp & Dohme LLC
University of Chicago
University of Chicago
City of Hope Medical Center
Hospital of Stomatology, Wuhan University
GlaxoSmithKline
University of Chicago
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
National Cancer Institute (NCI)
Children's Oncology Group
Merck KGaA, Darmstadt, Germany
Glycotope GmbH
Massachusetts General Hospital
AstraZeneca
Washington University School of Medicine
Washington University School of Medicine
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Celgene
University of Chicago
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Amgen
University of Chicago
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Emory University
Radiation Therapy Oncology Group
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Sanofi
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Dana-Farber Cancer Institute
Radiation Therapy Oncology Group
SCRI Development Innovations, LLC
Case Comprehensive Cancer Center